U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
86.27
+0.05 (0.06%)
At close: Oct 31, 2025, 4:00 PM EDT
86.12
-0.15 (-0.17%)
After-hours: Oct 31, 2025, 7:00 PM EDT
U.S. Physical Therapy Market Cap
U.S. Physical Therapy has a market cap or net worth of $1.31 billion as of October 31, 2025. Its market cap has increased by 3.70% in one year.
Market Cap
1.31B
Enterprise Value
1.58B
1-Year Change
3.70%
Ranking
Category
Stock Price
$86.27
Market Cap Chart
Since December 1, 1998, U.S. Physical Therapy's market cap has increased from $33.40M to $1.31B, an increase of 3,827.12%. That is a compound annual growth rate of 14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 1.31B | -2.05% |
| Dec 31, 2024 | 1.34B | -4.07% |
| Dec 29, 2023 | 1.40B | 32.50% |
| Dec 30, 2022 | 1.05B | -14.61% |
| Dec 31, 2021 | 1.23B | -20.16% |
| Dec 31, 2020 | 1.55B | 5.79% |
| Dec 31, 2019 | 1.46B | 12.51% |
| Dec 31, 2018 | 1.30B | 42.92% |
| Dec 29, 2017 | 908.40M | 3.34% |
| Dec 30, 2016 | 879.00M | 31.82% |
| Dec 31, 2015 | 666.80M | 29.53% |
| Dec 31, 2014 | 514.80M | 20.59% |
| Dec 31, 2013 | 426.90M | 30.63% |
| Dec 31, 2012 | 326.80M | 40.26% |
| Dec 30, 2011 | 233.00M | 1.00% |
| Dec 31, 2010 | 230.70M | 17.34% |
| Dec 31, 2009 | 196.60M | 23.34% |
| Dec 31, 2008 | 159.40M | -6.24% |
| Dec 31, 2007 | 170.00M | 20.14% |
| Dec 29, 2006 | 141.50M | -35.94% |
| Dec 30, 2005 | 220.90M | 15.17% |
| Dec 31, 2004 | 191.80M | 8.67% |
| Dec 31, 2003 | 176.50M | 34.94% |
| Dec 31, 2002 | 130.80M | -22.97% |
| Dec 31, 2001 | 169.80M | 118.25% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |